| REVIEW ARTICLES |
|
| Year : 2021 | Volume
: 14
| Issue : 3 | Page : 285-294 |
|
|
Intralesional agents in dermatology: Pros and cons
Jagdish Sakhiya1, Dhruv Sakhiya2, Jitesh Kaklotar1, Bansi Hirapara1, Madhav Purohit1, Krishna Bhalala1, Feral Daruwala1, Nimish Dudhatra1
1 Sakhiya Skin Clinic, 2nd Floor, Ayush Doctor House, Station-Lal Darwaja Road, Surat, Gujarat, India
2 B.J. Medical College, New Civil Hospital Asarwa, Ahmedabad, Gujarat, India
Correspondence Address:
Dr. Jagdish Sakhiya
Sakhiya Skin Clinic, 2nd Floor, Ayush Doctor House, Station-Lal Darwaja Road, Surat 395003, Gujarat.
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/JCAS.JCAS_109_20
|
|
|
Since introduced in 1961, intralesional (IL) agent has become an essential part of the dermatological practice. The term IL referred to the direct delivery of agent percutaneously into skin lesions. This therapeutic approach is relatively safe, easy to perform and applicable for a broad range of dermatological conditions. On the other hand, immediate side effects, including pain during administration, bleeding, high risk of infection and allergic reaction, and subsequent side effects involving skin changes such as atrophy, telangiectasia, pigmentary changes, and striae are usually associated with this modality. This review paper highlights the pros and cons of IL agents in modern dermatology practice. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
